Haemodynamics, fluids & transfusion

Acute Profound Hypotension Following Intraoperative Plasma Transfusion—A Case Series

Acta Anaesthesiol ScandPublished Case series

Authors' conclusion

Most transfusion reactions were characterized by profound and immediate hypotension following plasma transfusion, often presenting as isolated hypotension without biochemical or clinical evidence consistent with IgE-mediated anaphylaxis. A temporal association with the use of the Belmont Rapid Infuser RI-2 was observed. These findings should be regarded as hypothesis-generating, warranting further prospective mechanistic and safety studies.

Study context

Population
Patients with perioperative transfusion reactions at the Karolinska University Hospital, Sweden, June 2024 to June 2025patients with perioperative transfusion reactions included
Participants
Seventeen patients
Outcome
Hypotension
Methodological detailslocal quality registry
  • Local quality registry

Main finding

As reported in the abstract

Hypotension as the sole manifestation

11 cases

Observational data: associations, not effects.

Further findings

Elevated serum tryptase among the 11 with hypotension as sole manifestation

None of these 11 showed elevated serum tryptase levels

Transfusion details

Patients who also received packed red blood cells
seven
All patients except one received plasma via a Belmont Rapid Infuser RI-2

Blood pressure drop immediately after plasma infusion

Cases with blood pressure drop immediately after plasma infusion
11

Reactions in relation to Belmont Rapid Infuser withdrawal

Months

Belmont Rapid Infuser withdrawn after
7
No reactions were reported in the months following withdrawal
4
Reactions recurred following subsequent device use

Original publication

Acute Profound Hypotension Following Intraoperative Plasma Transfusion—A Case Series. Acta Anaesthesiol Scand. Published 25 October 2026. doi:10.1111/aas.70365

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.